Cite

HARVARD Citation

    Kalaycio, M. et al. (n.d.). Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: a phase I study in chronic lymphocytic leukemia*. Leukemia & lymphoma. 57 (4), pp. 803-811. [Online]. 
  
Back to record